首页> 外文期刊>Cancer Medicine >Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single‐institution retrospective analysis of 2163 Chinese patients
【24h】

Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single‐institution retrospective analysis of 2163 Chinese patients

机译:术前贫血对胃癌根治性切除术患者预后的影响:2163名中国患者的单机构回顾性分析

获取原文
           

摘要

We sought to evaluate whether preoperative anemia was an important determinant of survival in gastric cancer (GC). A single institution cohort of 2163 GC patients who underwent curative resection were retrospectively analyzed. Anemia was defined as a preoperative hemoglobin level 120?g/L in males and 110?g/L in females. Overall survival (OS) was analyzed using the Kaplan–Meier method, and a multivariate Cox proportional hazards model was performed to identify the independent prognostic factor. Anemic patients had a poorer OS compared with nonanemic patients after resection for tumor–nodes–metastasis (TNM) stage III tumors (5‐year OS rate: 32.2% vs. 45.7%, P ??0.001) but not stage I ( P ??=??0.480) or stage II ( P ??=??0.917) tumors. Multivariate analysis revealed that preoperative anemia was an independent prognostic factor in TNM stage III (hazard ratio [HR], 1.771; 95% CI, 1.040–3.015; P? = ? 0.035). In a stage‐stratified analysis, preoperative anemia was still independently associated with OS in TNM stages IIIa through IIIc ( P? ? 0.001, P? = ? 0.075, and P? = ? 0.012, respectively), though the association was only marginal in stage IIIb. Of note, preoperative mild anemia had a similar prognostic value in TNM stage III GC. Furthermore, preoperative anemia was significantly associated with more perioperative transfusions, postoperative complications and several nutritional‐based indices, including the prognostic nutritional index (PNI), preoperative weight loss and performance status (all P? ? 0.05). Preoperative anemia, even mild anemia, was an important predictor of postoperative survival for TNM stage III GC.
机译:我们试图评估术前贫血是否是胃癌(GC)生存的重要决定因素。回顾性分析了单一机构队列的2163例行根治性切除术的GC患者。贫血被定义为男性的术前血红蛋白水平<120?g / L,女性<110?g / L。使用Kaplan-Meier方法分析了总生存期(OS),并进行了多变量Cox比例风险模型来确定独立的预后因素。与非贫血患者相比,在手术切除后的无症状患者中,III期肿瘤淋巴结转移(TNM)(5年OS率:32.2%vs. 45.7%,P <0.001),而非I期(P Δε=Δε= 0.480)或II期(PΔε=Δε0.917)肿瘤。多因素分析显示,术前贫血是TNM III期的独立预后因素(危险比[HR]为1.771; 95%CI为1.040-3.015; P = 0.035)。在分期分层分析中,术前贫血仍独立于TNM IIIa至IIIc期的OS(P <0.001,P = 0.075,P = 0.012,P <0.01),尽管这种关联只是轻微的在IIIb阶段。值得注意的是,术前轻度贫血在TNM III期GC中具有相似的预后价值。此外,术前贫血与围手术期输血增多,术后并发症和多种基于营养的指标显着相关,包括预后营养指数(PNI),术前体重减轻和工作状态(所有P <0.05)。术前贫血,甚至是轻度贫血,也是TNM III期GC术后存活率的重要预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号